• Title/Summary/Keyword: Orofacial manifestations

Search Result 22, Processing Time 0.019 seconds

Orofacial Manifestations of Hyperparathyroidism: A Dental Perspective

  • Jo-Eun Park
    • Journal of Oral Medicine and Pain
    • /
    • v.49 no.2
    • /
    • pp.40-42
    • /
    • 2024
  • Hyperparathyroidism (HPT) is a significant condition marked by the overproduction of parathyroid hormones, affecting both systemic health and orofacial regions. Predominantly, secondary HPT associated with chronic kidney disease (CKD) is critical because of its link to widespread conditions such as diabetes and hypertension. This short article highlights the vital role of dental professionals in identifying HPT through panoramic radiography, which can reveal critical orofacial signs such as brown tumors, altered dental development, and specific bone changes. With the CKD prevalence expected to increase alongside an aging population, the importance of early detection of HPT and its manifestations in dental settings cannot be overstated. Dental practitioners play a crucial role in the early detection of HPT, emphasizing the importance of being knowledgeable about its orofacial manifestations.

Trismus as an Orofacial Manifestation of Acute Lymphoblastic Leukemia

  • Chae, Hwa Suk;Byun, Jin-Seok;Jung, Jae-Kwang;Choi, Jae-Kap
    • Journal of Oral Medicine and Pain
    • /
    • v.42 no.2
    • /
    • pp.49-52
    • /
    • 2017
  • Leukemia is a malignant disease characterized by uncontrolled clonal proliferation of white blood cells. It is classified depending on clinical course of disease (acute or chronic) and the primary hematopoietic cell line affected (myeloid or lymphoid). Leukemia is often associated with orofacial manifestations, such as oral bleeding, petechiae, oral ulceration, gingival enlargement, mucosal pallor and mental nerve neuropathy. However, trismus has been rarely reported as a sign of leukemia. We present a case of trismus caused by acute lymphoblastic leukemia and emphasize the importance of orofacial manifestations in the early diagnosis of leukemia.

Orthodontic and surgical management of cleidocranial dysplasia

  • Park, Tina Keun Nan;Vargervik, Karin;Oberoi, Snehlata
    • The korean journal of orthodontics
    • /
    • v.43 no.5
    • /
    • pp.248-260
    • /
    • 2013
  • Cleidocranial dysplasia (CCD), an autosomal dominant disorder with a prevalence of 1 in 1,000,000 individuals, is mainly caused by mutations in Runx2, a gene required for osteoblastic differentiation. It is generally characterized by hypoplastic clavicles, narrow thorax, and delayed or absent fontanel closure. Importantly, its orofacial manifestations, including midfacial hypoplasia, retained primary teeth, and impacted permanent and supernumerary teeth, severely impede the well-being of affected individuals. Successful treatment of the orofacial problems requires the combined efforts of dental specialists. However, only a few successfully treated cases have been reported because of the rarity of CCD and complexity of the treatment. This article presents the University of California, San Francisco (UCSF) treatment protocol for the dentofacial manifestations of CCD based on two treated and 17 diagnosed cases. The records of two patients with CCD who had been treated at the UCSF School of Dentistry and the treatment options reported in the literature were reviewed. The UCSF treatment protocol produced a successful case and a partially successful one (inadequate oral hygiene in the retention stage resulted in decay and loss of teeth). It provides general guidelines for successfully treating the orofacial manifestations of CCD.

Oral Symptoms Related to Vitamin B12 Deficiency in a Patient with Crohn's Disease

  • Lee, Joo-Hee;Park, Youn-Jung;Kwon, Jeong-Seung;Kim, Young-Gun;Ahn, Hyung-Joon
    • Journal of Oral Medicine and Pain
    • /
    • v.42 no.1
    • /
    • pp.25-27
    • /
    • 2017
  • Crohn's disease is an inflammatory bowel disease which affects whole gastrointestinal tract from mouth to anus. Crohn's disease may present both oral manifestation and gastrointestinal symptom-abdominal pain, diarrhea, weight loss, anorexia, fever, and growth failure. The prevalence rate of oral manifestation is approximately between 0.5% and 20%. The oral lesion could be the first sign of Crohn's disease. We present a case of Crohn's disease in a patient who did not show typical oral manifestations but had nonspecific aphthous like ulceration and burning sensation for many years. Through this case, we suggest approaches for the diagnosis and treatment of the oral lesion of Crohn's disease.

Oral Manifestation of Paraneoplastic Pemphigus

  • Kim, Seurin;Park, In Hee;Park, YounJung;Kwon, Jeong-Seung;Choi, Jong-hoon;Ahn, Hyung-Joon
    • Journal of Oral Medicine and Pain
    • /
    • v.44 no.3
    • /
    • pp.118-122
    • /
    • 2019
  • Paraneoplastic pemphigus (PNP) is a rare and often fatal autoimmune blistering disease accompanied by both benign and malignant neoplasms. Usually, oral, skin, and mucosal lesions are the earliest manifestations shown by PNP patients. Oral ulcers are initial lesions in various autoimmune diseases like pemphigus, bullous pemphigoid, erythema multiforme, graft-versus-host, lichen planus, it does not improved despite of high-dose steroid therapy. We report a-35-year-old female who presented oral ulceration, lip crust and skin lesions. By doing several examinations, such as enzyme-linked immunosorbent assay, incisional biopsy with indirect immunofluorescence, she was diagnosed PNP with non-Hodgkin's lymphoma on pancreas.

Fibromyalgia: practical considerations for oral health care providers

  • Jeon, Younghoon
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • v.20 no.5
    • /
    • pp.263-269
    • /
    • 2020
  • Fibromyalgia is a syndrome characterized by chronic pain in the skeletal system accompanied by stiffness, sleep disturbance, fatigue, and psychiatric problems, such as anxiety and depression. Fibromyalgia commonly affects orofacial health, presenting with a variety of oral manifestations, including temporomandibular disorder, xerostomia, glossodynia, and dysgeusia. Therefore, oral healthcare providers need to be aware of this clinical entity to effectively manage oral symptoms and provide proper oral self-care modification and education on the nature of fibromyalgia. This review focuses on the epidemiology, pathophysiology, clinical manifestation, diagnosis, orofacial concerns, and treatment of fibromyalgia.

A Case of Aphthous Stomatitis in a Healthy Adult Following COVID-19 Vaccination: Clinical Reasoning

  • Kim, Hye Kyoung;Kim, Mee Eun
    • Journal of Oral Medicine and Pain
    • /
    • v.47 no.1
    • /
    • pp.62-66
    • /
    • 2022
  • Recent case studies raised the possibility that cutaneous and oral mucosal manifestations may be associated with the coronavirus disease 2019 (COVID-19) vaccination. A healthy 43-year-old male presented an acute aphthous stomatitis following Moderna COVID-19 vaccination. This rare case draws attention to a potential etiologic effect for oral mucosal manifestation from COVID-19 vaccination. Further investigation to shed light on prevalence and pathophysiologic association of this oral lesion and COVID-19 vaccination deserve attention.

A Primary Sjögren's Syndrome Patient Presented with Severe General Toothache

  • Lee, Yeon-Hee;Kho, Hong-Seop
    • Journal of Oral Medicine and Pain
    • /
    • v.40 no.3
    • /
    • pp.130-134
    • /
    • 2015
  • $Sj{\ddot{o}}gren's$ syndrome (SS) is an autoimmune disease characterized by an autoimmune exocrinopathy involving mainly salivary and lacrimal glands. Apart from manifestations due to involvement of exocrine glands, patients with SS can present with muscular and neurological manifestations. Here, we report a rare case of a 59-year-old woman with primary SS, who presented with severe general toothache and masticatory muscle myalgia successfully treated with clonazepam. Although it was not certain that these symptoms could be originated from focal muscle dystonia or neurological changes that are associated with primary SS, our case suggested that comprehensive evaluation including neuromuscular examinations in the oral and maxillofacial area is needed in patients with SS.

A Case Report on Oro-Facial Manifestations in Leukemia (Oral Chronic GVHD) (백혈병 환자의 구강악안면 증상 발현에 관한 증례보고 (Oral Chronic GVHD))

  • Ahn, Hyoung-Joon;Kwon, Byung-Ki;Shin, Kyoung-Jin;Choi, Jong-Hoon;Kim, Chong-Youl
    • Journal of Oral Medicine and Pain
    • /
    • v.25 no.2
    • /
    • pp.159-165
    • /
    • 2000
  • Subsequent to an allogenic stem cell transplantation(ASCT) on patients with hematologic malignancy(AML, ALL, CML, multiple myeloma, lymphoma etc.), chronic GVHD(graft versus host disease), which is an immunological reaction, occurs. With treatment results from patients who were diagnosed with ALL(acute lymphocytic leukemia), undergone BMT(bone marrow transplantation) and showed oral and skin lesions due to GVHD, treatment of oral manifestations of leukemia and its general management were studied. 90% of patients with chronic GVHD show change in the oral mucosa causing oral manifestations such as leukoplakia, lichenoid change of the oral mucosa, mucosal atrophy, erythema, ulceration and xerostomia. In treating GVHD, extensive systemic immunosuppression cause bacterial, viral, fungal infection that are fatal, and even if the treatment is successful, the patient is already in a severe immunosuppressed state. Therefore, localized target therapy is preferred. In another words, topical application(rinse, cream, ointment etc.) of cyclosporin and steroid in treating oral chronic GVHD is highly recommended, and the use of PUVA(Psoralen Ultraviolet A) and thalidomide is reported to be effective. In treating such diseases, dental treatment to control pain and prevent secondary infection of oral manifestations is very important. To those patients with systemic diseases who show limited effect by general dental treatment, non-invasive treatment such as the dental laser, in addition to the use of drugs, may be necessary to actively treat pain and help the healing process. For greater results, new effective methods are to be developed for treatment.

  • PDF

Oral Manifestations of Human Immunodeficiency Virus Infection: Early Diagnostic Indicators

  • Hee-Won Kim;Yong-Woo Ahn;Sung-Hee Jeong;Soo-Min Ok;Hye-Min Ju
    • Journal of Oral Medicine and Pain
    • /
    • v.49 no.3
    • /
    • pp.65-70
    • /
    • 2024
  • This paper highlights the importance of oral manifestations as indicators for early human immunodeficiency virus (HIV) detection through two case studies. HIV, responsible for acquired immunodeficiency syndrome (AIDS), damages CD4+ T-lymphocytes, leading to severe immunosuppression and increased vulnerability to various infections. Oral lesions often appear early in HIV infection and can signal disease progression. The study underscores the role of dentists in identifying these lesions, which can serve as crucial markers for HIV. We used two cases to illustrate the importance of screening in HIV patients. The first was a patient presented with oral soreness and a mass on his tongue. Despite having a positive HIV test result in a previous medical examination, but patient had intentionally concealed his infection. The second was a patient experienced dry mouth and burning sensation, with symptoms unresponsive to repeated antifungal treatments and suspected esophageal fungal infection. This led to the discovery of an HIV-positive status in a patient previously unaware of his infection. In both cases, oral manifestations played a crucial role in the early diagnosis of HIV/AIDS. These manifestations can be particularly useful for identifying HIV in patients who are asymptomatic or unaware of their status. Although oral lesions, such as oral candidiasis and oral hairy leukoplakia, are not exclusive to HIV but are more prevalent and severe in HIV-positive individuals. The findings support routine HIV screening and the critical role of dentists in recognizing oral signs of HIV infection to facilitate early diagnosis and treatment.